2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with citalopram in 4 studies
Studies (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Trials (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Recent Studies (post-2010) (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Studies (citalopram) | Trials (citalopram) | Recent Studies (post-2010) (citalopram) |
---|---|---|---|---|---|
135 | 6 | 50 | 5,348 | 1,424 | 2,350 |
Protein | Taxonomy | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (IC50) | citalopram (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.297 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.196 | |
Aromatase | Rattus norvegicus (Norway rat) | 0.0018 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.196 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.289 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.297 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0227 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0027 | |
Histamine H1 receptor | Homo sapiens (human) | 3.194 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.839 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1869 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.398 | |
Transporter | Rattus norvegicus (Norway rat) | 8.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Bomsien, S; Skopp, G | 1 |
Barbera, N; Busardò, FP; Indorato, F; Romano, G | 1 |
Ihenetu, K; Na, S; Rosano, TG; Swift, TA; Wood, M | 1 |
4 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and citalopram
Article | Year |
---|---|
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |
The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome.
Topics: Adult; Anesthetics, Local; Antitussive Agents; Bile; Brain Chemistry; Caffeine; Central Nervous System Stimulants; Citalopram; Codeine; Dextromethorphan; Drug Contamination; Drug Overdose; Drug Users; Female; Forensic Pathology; Forensic Toxicology; Gastrointestinal Contents; Humans; Illicit Drugs; Kidney; Lidocaine; Liver; Lung; Male; Methadone; Morphine; Morphine Derivatives; Narcotics; Pyrrolidines; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Vitreous Body | 2013 |
Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Cocaine; Codeine; Dextromethorphan; Diphenhydramine; Evaluation Studies as Topic; Forensic Pathology; Humans; Hydrocodone; Hydromorphone; Meperidine; Methadone; Morphine; Oxycodone; Oxymorphone; Pyrrolidines; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |